Navigation Links
Shares Of AVI BioPharma Drops On Reports Of Disappointing Early Drug Trail

Shares of AVI BioPharma Inc. has lost a third of their value on Wednesday after the company reported disappointing clinical trial data for its experimental treatment against the hepatitis C virus. //

The shares of AVI were down $2.43, or 33 percent, to $4.83, in the heavy morning trade on the Nasdaq.

The Portland, Oregon based biotechnology company said that the results came from the second stage of a trial involving the antisense drug, called AVI-4065, among patients infected with the liver-damaging virus. Company officials have said that the drug showed favourable safety in all patients treated so far, but patients have experienced only a mean "slight decrease" in the amount of virus in their bloodstreams both during and after treatment.

In a press release the company officials said that during the 14 days of treatment, three of five patients evaluated had an initial decrease in viral load, whereas two of five exhibited little initial change. They were quick to point out that the results were still only preliminary and in only a small number of patients, and that patients remained enrolled in the study. They stated that the formal results of the trial were expected around the end of the year.

Antisense drugs, like AVI-4065, are artificial pieces of genetic material that are meant to prevent genes from expressing disease-causing proteins. Sadly the technology has not yet achieved great success despite high earlier hopes.


'"/>




Page: 1

Related medicine news :

1. ViroPharma Shares Fall As FDA Moves Towards Generic Vancocin
2. Sun Pharma Allots Shares Upon Fccbs Conversion
3. Zenotech Issues 20 Lakh Shares to Ranbaxy for Rs 20 Cr
4. Female Ratio Drops Alarmingly In Himachal Due To Feticides
5. 1.8 mn Delhi Children to Receive Anti-polio Drops
6. Antibiotic Ear Drops Favored Over Oral Antibiotics for Ear Infections
7. No Smoking During Play Rehearsals: UK’s Health Ministry Drops the Curtain
8. Russia Reports First SARS Case
9. Uganda Reports Failure To Contain Sleeping Sickness
10. Reports of Hantavirus infection in India raise concerns
11. Controversy Surrounding The HIV Positive Reports Of One-Year Girl In Kerala
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/6/2016)... ... February 06, 2016 , ... ... MEDIA ADVISORY: 5000 PERIOPERATIVE NURSES EXPECTED AT AORN SURGICAL CONFERENCE & EXPO ... in the world with an estimated 5000 perioperative nurses in attendance to ...
(Date:2/5/2016)... ... February 05, 2016 , ... Steven Tonkinson, 36, of ... completed every year since it started in 2003. This year, he ran all 26.2 ... fellow runners and NBA team the Miami Heat. , This Sunday, while many are ...
(Date:2/5/2016)... ... February 05, 2016 , ... The event is being held ... Event Center in Minneapolis, Minn. Triumph Over Parkinson’s will fund nearly $100,000 for research ... Schneiderman’s Furniture, lives with Parkinson’s disease and is the architect of this informative event ...
(Date:2/5/2016)... ... February 05, 2016 , ... After years as an active staff surgeon ... and cosmetic surgeon Dr. Wayne Carman transitioned to chief of the Division of Plastic ... first three-year term as chief and began a second three-year term in January of ...
(Date:2/5/2016)... York, New York (PRWEB) , ... February 05, 2016 , ... ... gym use and find themselves having to wait longer to access the treadmills. It’s ... their New Year’s resolutions to lose weight and get in shape by joining gyms, ...
Breaking Medicine News(10 mins):
(Date:2/4/2016)... Medical, Inc. (Nasdaq: AEMD ), the pioneer ... diseases, today announced results for the third quarter ... --> --> "Beyond ... quarterly call, we strategically advanced pre-clinical and clinical ... the Aethlon Hemopurifier® as a leading broad-spectrum countermeasure ...
(Date:2/4/2016)... N.Y. , Feb. 4, 2016  AMRI (NASDAQ:  AMRI) ... President of Pfizer Inc. and President of Pfizer Global Supply, ... as of February 4, 2016. In addition, the Company announced ... of the audit committee since 2010, has retired from the ... and attention to his other business ventures.  ...
(Date:2/4/2016)... PUNE, India , February 4, 2016 ... to the new Market Research Report "North American Automated ... and Fully-Automated External Defibrillators), by End-User (Public Facilities, Hospitals, ... North American automated external defibrillators (AED) report defines and ... of the revenue. This market is estimated to grow ...
Breaking Medicine Technology: